Foxo1 links hyperglycemia to LDL oxidation and endothelial nitric oxide synthase dysfunction in vascular endothelial cells

Diabetes. 2009 Oct;58(10):2344-54. doi: 10.2337/db09-0167. Epub 2009 Jul 7.

Abstract

Objective: Atherosclerotic cardiovascular disease is the leading cause of death among people with diabetes. Generation of oxidized LDLs and reduced nitric oxide (NO) availability because of endothelial NO synthase (eNOS) dysfunction are critical events in atherosclerotic plaque formation. Biochemical mechanism leading from hyperglycemia to oxLDL formation and eNOS dysfunction is unknown.

Research design and methods: We show that glucose, acting through oxidative stress, activates the transcription factor Foxo1 in vascular endothelial cells.

Results: Foxo1 promotes inducible NOS (iNOS)-dependent NO-peroxynitrite generation, which leads in turn to LDL oxidation and eNOS dysfunction. We demonstrate that Foxo1 gain-of-function mimics the effects of hyperglycemia on this process, whereas conditional Foxo1 knockout in vascular endothelial cells prevents it.

Conclusions: The findings reveal a hitherto unsuspected role of the endothelial iNOS-NO-peroxynitrite pathway in lipid peroxidation and eNOS dysfunction and suggest that Foxo1 activation in response to hyperglycemia brings about proatherogenic changes in vascular endothelial cell function.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Aorta / enzymology
  • Blood Glucose / metabolism
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / prevention & control
  • Cell Cycle Proteins
  • Diabetic Angiopathies / epidemiology
  • Diabetic Angiopathies / genetics
  • Diabetic Angiopathies / mortality
  • Diabetic Angiopathies / prevention & control
  • Endothelium, Vascular / enzymology
  • Endothelium, Vascular / physiology*
  • Endothelium, Vascular / physiopathology
  • Forkhead Box Protein O1
  • Forkhead Box Protein O3
  • Forkhead Transcription Factors / genetics
  • Forkhead Transcription Factors / metabolism
  • Forkhead Transcription Factors / physiology*
  • Humans
  • Hyperglycemia / enzymology
  • Hyperglycemia / genetics
  • Hyperglycemia / physiopathology*
  • Insulin Resistance / physiology
  • Lipoproteins, LDL / metabolism*
  • Mice
  • Microcirculation / physiology*
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type III / genetics
  • Nitric Oxide Synthase Type III / metabolism*
  • Oxidation-Reduction
  • RNA / genetics
  • RNA / isolation & purification
  • Risk Factors
  • Transcription Factors / genetics

Substances

  • Blood Glucose
  • Cell Cycle Proteins
  • FOXO1 protein, human
  • FOXO3 protein, human
  • FOXO4 protein, human
  • Forkhead Box Protein O1
  • Forkhead Box Protein O3
  • Forkhead Transcription Factors
  • Foxo1 protein, mouse
  • Lipoproteins, LDL
  • Transcription Factors
  • RNA
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III